We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 11, 2021

High- and Low-Efficacy Therapy in Secondary Progressive MS



Additional Info

Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Neurology 2021 Aug 01;9(11)e869-e880, I Roos, E Leray, R Casey, D Horakova, E Havrdova, G Izquierdo, SE Madueño, F Patti, G Edan, M Debouverie, J Pelletier, S Ozakbas, MP Amato, P Clavelou, P Grammond, C Boz, K Buzzard, O Skibina, J Ciron, O Gerlach, F Grand'Maison, J Lechner-Scott, C Malpas MPsych CliNeuro, H Butzkueven, S Vukusic, T Kalincik

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading